Sort by

Send to

Choose Destination

Search results

Items: 16


Dual-Gated Motion-Frozen Cardiac PET with Flurpiridaz F 18.

Slomka PJ, Rubeaux M, Le Meunier L, Dey D, Lazewatsky JL, Pan T, Dweck MR, Newby DE, Germano G, Berman DS.

J Nucl Med. 2015 Dec;56(12):1876-81. doi: 10.2967/jnumed.115.164285.


Assessment of Myocardial Remodeling Using an Elastin/Tropoelastin Specific Agent with High Field Magnetic Resonance Imaging (MRI).

Protti A, Lavin B, Dong X, Lorrio S, Robinson S, Onthank D, Shah AM, Botnar RM.

J Am Heart Assoc. 2015 Aug 13;4(8):e001851. doi: 10.1161/JAHA.115.001851.


Retention Kinetics of the 18F-Labeled Sympathetic Nerve PET Tracer LMI1195: Comparison with 11C-Hydroxyephedrine and 123I-MIBG.

Werner RA, Rischpler C, Onthank D, Lapa C, Robinson S, Samnick S, Javadi M, Schwaiger M, Nekolla SG, Higuchi T.

J Nucl Med. 2015 Sep;56(9):1429-33. doi: 10.2967/jnumed.115.158493.


Multimodality and molecular imaging of matrix metalloproteinase activation in calcific aortic valve disease.

Jung JJ, Razavian M, Challa AA, Nie L, Golestani R, Zhang J, Ye Y, Russell KS, Robinson SP, Heistad DD, Sadeghi MM.

J Nucl Med. 2015 Jun;56(6):933-8. doi: 10.2967/jnumed.114.152355.


A Phase I-II, Open-Label, Multicenter Trial to Determine the Dosimetry and Safety of 99mTc-Sestamibi in Pediatric Subjects.

Azarbar S, Salardini A, Dahdah N, Lazewatsky J, Sparks R, Portman M, Crane PD, Lee ML, Zhu Q.

J Nucl Med. 2015 May;56(5):728-36. doi: 10.2967/jnumed.114.146795.


PET/CT and MR imaging biomarker of lipid-rich plaques using [64Cu]-labeled scavenger receptor (CD68-Fc).

Bigalke B, Phinikaridou A, Andia ME, Cooper MS, Schuster A, Wurster T, Onthank D, Münch G, Blower P, Gawaz M, Nagel E, Botnar RM.

Int J Cardiol. 2014 Nov 15;177(1):287-91. doi: 10.1016/j.ijcard.2014.09.017.


Biodistribution and radiation dosimetry of LMI1195: first-in-human study of a novel 18F-labeled tracer for imaging myocardial innervation.

Sinusas AJ, Lazewatsky J, Brunetti J, Heller G, Srivastava A, Liu YH, Sparks R, Puretskiy A, Lin SF, Crane P, Carson RE, Lee LV.

J Nucl Med. 2014 Sep;55(9):1445-51. doi: 10.2967/jnumed.114.140137.


Acute mortality in critically ill patients undergoing echocardiography with or without an ultrasound contrast agent.

Main ML, Hibberd MG, Ryan A, Lowe TJ, Miller P, Bhat G.

JACC Cardiovasc Imaging. 2014 Jan;7(1):40-8. doi: 10.1016/j.jcmg.2013.08.012.


Cardiac retention of PET neuronal imaging agent LMI1195 in different species: impact of norepinephrine uptake-1 and -2 transporters.

Yu M, Bozek J, Kagan M, Guaraldi M, Silva P, Azure M, Onthank D, Robinson SP.

Nucl Med Biol. 2013 Jul;40(5):682-8. doi: 10.1016/j.nucmedbio.2013.03.003.


LMI1195 PET imaging in evaluation of regional cardiac sympathetic denervation and its potential role in antiarrhythmic drug treatment.

Yu M, Bozek J, Lamoy M, Kagan M, Benites P, Onthank D, Robinson SP.

Eur J Nucl Med Mol Imaging. 2012 Dec;39(12):1910-9. doi: 10.1007/s00259-012-2204-y.


Synthesis and Cardiac Imaging of (18)F-Ligands Selective for β1-Adrenoreceptors.

Radeke HS, Purohit A, Harris TD, Hanson K, Jones R, Hu C, Yalamanchili P, Hayes M, Yu M, Guaraldi M, Kagan M, Azure M, Cdebaca M, Robinson S, Casebier D.

ACS Med Chem Lett. 2011 Jul 22;2(9):650-5. doi: 10.1021/ml1002458.


The next generation of cardiac positron emission tomography imaging agents: discovery of flurpiridaz F-18 for detection of coronary disease.

Yu M, Nekolla SG, Schwaiger M, Robinson SP.

Semin Nucl Med. 2011 Jul;41(4):305-13. doi: 10.1053/j.semnuclmed.2011.02.004. Review.


Evaluation of LMI1195, a novel 18F-labeled cardiac neuronal PET imaging agent, in cells and animal models.

Yu M, Bozek J, Lamoy M, Guaraldi M, Silva P, Kagan M, Yalamanchili P, Onthank D, Mistry M, Lazewatsky J, Broekema M, Radeke H, Purohit A, Cdebaca M, Azure M, Cesati R, Casebier D, Robinson SP.

Circ Cardiovasc Imaging. 2011 Jul;4(4):435-43. doi: 10.1161/CIRCIMAGING.110.962126.


Women and heart disease.

Lee LV, Foody JM.

Cardiol Clin. 2011 Feb;29(1):35-45. doi: 10.1016/j.ccl.2010.11.002. Review.


Cardiac imaging and safety evaluation of BMS747158, a novel PET myocardial perfusion imaging agent, in chronic myocardial compromised rabbits.

Yu M, Bozek J, Guaraldi M, Kagan M, Azure M, Robinson SP.

J Nucl Cardiol. 2010 Aug;17(4):631-6. doi: 10.1007/s12350-010-9221-7.


Effects of food intake and anesthetic on cardiac imaging and uptake of BMS747158-02 in comparison with FDG.

Yu M, Guaraldi MT, Bozek J, Kagan M, Azure M, Radeke H, Cdebaca M, Robinson SP.

J Nucl Cardiol. 2009 Sep-Oct;16(5):763-8. doi: 10.1007/s12350-009-9088-7.

Items per page

Supplemental Content

Loading ...
Support Center